Log in

News

  • Home
  • Resources
  • Literature Updates
  • Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201

Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201

11 Dec 2019 6:01 AM | Anonymous

Syma Iqbal, MD; Shannon McDonough, MS; Heinz-Josef Lenz, MD; David Ilson, MD, PhD; Barbara Burtness, MD; Chaitali S. Nangia, MD; Afsaneh Barzi, MD, PhD; Charles J. Schneider, MD; Jane Jijun Liu, MD; Efrat Dotan, MD; Katherine A. Guthrie, PhD; and Howard S. Hochster, MD.

Click here to read the full abstract.

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software